Philipp Georg

Medicine · Health Sciences

15h-index4.4kcitations26works7.72yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

SARS-CoV-2 and COVID-19 Research(13), COVID-19 Clinical Research Studies(11), interferon and immune responses(7), Immunotherapy and Immune Responses(6), T-cell and B-cell Immunology(4)

Publications26 total

Rewired type I IFN signaling is linked to age-dependent differences in COVID-19
Cell Reports Medicine·2025Open Access
Rewired type I IFN signaling is linked to age-dependent differences in COVID-19
2024Open Access
The life-saving benefit of dexamethasone in severe COVID-19 is linked to a reversal of monocyte dysregulation
Cell·2024· 23 citedOpen Access
Single-cell RNA sequencing uncovers the nuclear decoy lincRNA PIRAT as a regulator of systemic monocyte immunity during COVID-19
Proceedings of the National Academy of Sciences·2022· 38 citedOpen Access
Complement activation induces excessive T cell cytotoxicity in severe COVID-19
Cell·2021· 217 citedOpen Access
Complement activation induces excessive T cell cytotoxicity in severe COVID-19: Analysis of single cell data cohort 1 (Berlin).
2021Open Access
Complement activation induces excessive T cell cytotoxicity in severe COVID-19: Analysis of single cell data cohort 1 (Berlin).
Zenodo (CERN European Organization for Nuclear Research)·2021Open Access
Complement activation induces excessive T cell cytotoxicity in severe COVID-19: Analysis of single cell data cohort 1 (Berlin).
Zenodo (CERN European Organization for Nuclear Research)·2021Open Access
Single cell RNA-seq uncovers the nuclear decoy lincRNA PIRAT as a regulator of systemic monocyte immunity during COVID-19
2021Open Access
Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort study
The Lancet Respiratory Medicine·2021· 352 citedOpen Access
Impact of dexamethasone on SARS-CoV-2 concentration kinetics and antibody response in hospitalized COVID-19 patients: results from a prospective observational study
Clinical Microbiology and Infection·2021· 18 citedOpen Access
A time-resolved proteomic and prognostic map of COVID-19
Cell Systems·2021· 212 citedOpen Access
Complement activation induces excessive T cell cytotoxicity in severe COVID-19
2021· 3 citedOpen Access
Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1-nCoV19 and BNT162b2: a prospective cohort study
2021· 73 citedOpen Access
Complement Activation Induces Excessive T Cell Cytotoxicity in Severe COVID-19
SSRN Electronic Journal·2021· 24 citedOpen Access
Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment
Cell·2020· 1.6k citedOpen Access
SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19
Nature·2020· 1.4k citedOpen Access
Presence of SARS-CoV-2-reactive T cells in COVID-19 patients and healthy donors
2020· 178 citedOpen Access
Noncoding RNA <i>MaIL1</i> is an integral component of the TLR4–TRIF pathway
Proceedings of the National Academy of Sciences·2020· 55 citedOpen Access
Innate sensors that regulate vaccine responses
Current Opinion in Immunology·2019· 34 cited
page 1 of 2Next →

Frequent Co-authors

Leif Erik Sander(19), Norbert Suttorp(13), Florian Kurth(13), Birgit Sawitzki(12), Victor M. Corman(11), Sophia Brumhard(10), Daniel Wendisch(9), Charlotte Thibeault(9), Elisa T. Helbig(9), Lorenzo Bonaguro(8), Stefan Hippenstiel(8), Pinkus Tober‐Lau(8), Lena J. Lippert(8), Rosario Astaburuaga-García(8), Nils Blüthgen(8), David Hillus(7), Holger Müller-Redetzky(6), Alexander Uhrig(6), Emanuel Wyler(6), Christian Meisel(6)